Arrowhead Pharma Market Sentiment

SPY770.11 QQQ717.81−1.07%BTC/USD80,146.80−1.35%DIA527.50+0.54%GLD368.77−1.27%TLT81.40+0.51%

Premium Services

Arrowhead Pharmaceuticals Inc

ARWRNASDAQ

Trade with Public

$60.21

1.182%

Last update: Oct 29, 4:56 AM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Arrowhead Pharma Market Sentiment - Benzinga

Arrowhead Pharma Market Sentiment

Market sentiment signals for Arrowhead Pharma (ARWR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 10.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

—

Avg Consensus PT

$89

+48.2%

Highest Price Target

$126

+109.2%

Piper Sandler

Lowest Price Target

$17

-71.8%

Citigroup

Short Interest

10.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	UBS	John Lee—	+80.9%	$63 → $109	Assumes	Buy
Oct 15, 2026	Chardan Capital	Keay Nakae—	+90.9%	$115 → $115	Maintained	Buy
Oct 15, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+99.2%	$120 → $120	Maintained	Buy
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+22.8%	$74	Reinstates	Neutral
Sep 8, 2026	Citigroup	Eric Joseph—	+79.3%	$108	Initiate	Buy
Sep 1, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+99.2%	$120 → $120	Maintained	Buy
Aug 31, 2026	Chardan Capital	Keay Nakae—	+90.9%	$115 → $115	Maintained	Buy
Aug 31, 2026	RBC Capital	Luca Issi—	+66.0%	$100 → $100	Maintained	Outperform
Aug 6, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+99.2%	$115 → $120	Maintained	Buy
Jul 30, 2026	B. Riley Securities	Madison El-Saadi—	+104.2%	$101 → $123	Maintained	Buy
Jul 27, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+90.9%	$100 → $115	Maintained	Buy
Jul 23, 2026	Morgan Stanley	Michael Ulz—	+99.2%	$100 → $120	Maintained	Overweight
Jul 23, 2026	Piper Sandler	Edward Tenthoff—	+109.2%	$110 → $126	Maintained	Overweight
Jul 22, 2026	Chardan Capital	Keay Nakae—	+90.9%	$90 → $115	Maintained	Buy
Jul 17, 2026	JP Morgan	Brian Cheng—	+57.7%	$88 → $95	Maintained	Overweight
Jul 14, 2026	Stifel	James Condulis—	+62.7%	$98	Initiate	Buy
Jul 1, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+66.0%	$100 → $100	Maintained	Buy
Jun 30, 2026	Chardan Capital	Keay Nakae—	+49.4%	$90 → $90	Maintained	Buy
Jun 17, 2026	Leerink Partners	Mani Foroohar—	+19.5%	$61 → $72	Maintained	Market Perform
May 13, 2026	Bernstein	William Pickering—	-23.6%	$35 → $46	Maintained	Market Perform
May 8, 2026	RBC Capital	Luca Issi—	+44.4%	$80 → $87	Maintained	Outperform
May 1, 2026	JP Morgan	Brian Cheng—	+46.1%	$88	Initiate	Overweight
Apr 21, 2026	Morgan Stanley	Michael Ulz—	+66.0%	$78 → $100	Upgrade	Equal-Weight→Overweight
Mar 25, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+66.0%	$100 → $100	Maintained	Buy
Feb 10, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+66.0%	$100 → $100	Maintained	Buy